ENO1 and bladder transitional cell carcinoma: Furthermore, the ROC curve manifested that ENO1 exerted good performance in anticipating the survival rates of BLCA patients (Additional file 2: Fig. S1C), and subsequent multi-variable time-dependent ROC analysis revealed that ENO1 exhibited higher AUC value relative to other clinicopathological parameters (Additional file 2: Fig. S1D).